학술논문
Effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis: A multicenter study in China
Document Type
article
Author
Qiping Ge; Yan Ma; Lijie Zhang; Liping Ma; Caiyan Zhao; Yuhui Chen; Xuerui Huang; Wei Shu; Shengyu Chen; Fei Wang; Bo Li; Xiqin Han; Lian Shi; Xin Wang; Youlun Li; Shangpeng Yang; Wenli Cao; Qianying Liu; Ling Chen; Chao Wu; Bing Ouyang; Furong Wang; Po Li; Xiang Wu; Xiue Xi; Xueyan Leng; Haiqing Zhang; Hua Li; Juan Li; Chengqing Yang; Peng Zhang; Hongzhe Cui; Yuhong Liu; Chengcheng Kong; Zhaogang Sun; Jian Du; Weiwei Gao
Source
Frontiers in Public Health, Vol 11 (2023)
Subject
Language
English
ISSN
2296-2565
Abstract
Background and objectiveRetreatment pulmonary tuberculosis (PTB) still accounts for a large proportion of tuberculosis, and the treatment outcome is unfavorable. The recurrence of retreatment PTB based on long-term follow-up has not been well demonstrated. This study aimed to evaluate effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis.MethodsThis multicenter cohort study was conducted in 29 hospitals from 23 regions of China from July 1, 2009, to December 31, 2020. Patients were divided into two treatment regimen groups including experimental group [modified regimen (4H-Rt2-E-Z-S(Lfx)/4H-Rt2-E)]and control group [standard regimen (2H-R-E-Z-S/6H-R-E or 3H-R-E-Z/6H-R-E)]. The patients enrolled were followed up of 56 months after successful treatment. We compared the treatment success rate, treatment failure rate, adverse reaction rate, and recurrence rate between two regimens. Multivariate Cox regression model was used to identify the potential risk factors for recurrence after successful treatment with proportional hazards assumptions tested for all variables.ResultsA total of 381 patients with retreatment PTB were enrolled, including 244 (64.0%) in the experimental group and 137 (36.0%) in the control group. Overall, the treatment success rate was significant higher in the experimental group than control group (84.0 vs. 74.5%, P = 0.024); no difference was observed in adverse reactions between the two groups (25.8 vs. 21.2%, P > 0.05). A total of 307 patients completed the 56 months of follow-up, including 205 with the modified regimen and 102 with the standard regimen. Among these, 10 cases (3.3%) relapsed, including 3 in the experimental group and 7 in the control group (1.5% vs 6.9%, P = 0.035). Reduced risks of recurrence were observed in patients treated with the modified regimen compared with the standard regimen, and the adjusted hazard ratio was 0.19 (0.04–0.77).ConclusionThe modified retreatment regimen had more favorable treatment effects, including higher treatment success rate and lower recurrence rate in patients with retreated drug-sensitive PTB.